Reduced sympathetic responsiveness as well as plasma and tissue noradrenaline concentration in growth hormone transgenic mice

Acta Physiologica Scandinavica

Volumn 182, Issue 4, 2004, Pages 369-378

  Andersson, I J ^a   Barlind, A ^a   Nystrom H C ^a   Olsson, B ^a   Skott O ^b   Mobini, R ^c   Johansson, M ^a   Bergstrom G ^a,d  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Acromegaly; Autonomic function; Growth hormone; Heart rate; Parasympathetic nervous system; Sympathetic nervous system

Indexed keywords

GROWTH HORMONE; METHYLSCOPOLAMINE; NORADRENALIN;

ACROMEGALY; ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTONOMIC NERVOUS SYSTEM FUNCTION; CHOLINERGIC SYSTEM; CONFERENCE PAPER; CONTROLLED STUDY; HEART RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE RESPONSE; MOUSE; NONHUMAN; NORADRENALIN BLOOD LEVEL; NORADRENALIN RELEASE; PRIORITY JOURNAL; RECEPTOR BLOCKING; RECEPTOR DOWN REGULATION; TELEMETRY; TRANSGENIC MOUSE;

ACROMEGALY; AGING; ANIMALS; BODY WEIGHT; CATTLE; CIRCADIAN RHYTHM; FEMALE; GROWTH HORMONE; HEART RATE; KIDNEY; MICE; MICE, TRANSGENIC; NOREPINEPHRINE; ORGAN SIZE; PARASYMPATHETIC NERVOUS SYSTEM; RENIN; SYMPATHETIC NERVOUS SYSTEM; TELEMETRY;

EID: 10344259174     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-201X.2004.01368.x     Document Type: Conference Paper

References (32)

1. Aberg, M.A.I., Aberg, N.D., Hedbacker, H., Oscarsson, J. & Eriksson, P.S. 2000. Peripheral infusion of igf-i selectively induces neurogenesis in the adult rat hippocampus. J Neurosci 20, 2896-2903.
2. Bigger, J.T. Jr., Fleiss, J.L., Steinman, R.C., Rolnitzky, L.M., Kleiger, R.E. & Rottman, J.N. 1992. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 85, 164-171.
3. Bohlooly, Y.M., Carlson, L., Olsson, B. et al. 2001. Vascular function and blood pressure in gh transgenic mice. Endocrinology 142, 3317-3323.
4. Bollano, E., Omerovic, E., Bohlooly-Y, M. et al. 2000. Impairment of cardiac function and bioenergetics in adult transgenic mice overexpressing the bovine growth hormone gene. Endocrinology 141, 2229-2235.
5. Bondanelli, M., Ambrosio, M.R., Franceschetti, P., Margutti, A., Trasforini, G. & Degli Uberti, E.C. 1999. Diurnal rhythm of plasma catecholamines in acromegaly. J Clin Endocrinol Metab 84, 2458-2467.
6. Capaldo, B., Lembo, G., Rendina, V. et al. 1998. Sympathetic deactivation by growth hormone treatment in patients with dilated cardiomyopathy. Eur Heart J 19, 623-627.
7. Capaldo, B., Lembo, G., Rendina, V. et al. 2000. Muscle sympathetic nerve activity in patients with acromegaly. J Clin Endocrinol Metab 85, 3203-3207.
8. Connell, J.M.C. & Davies, D.L. 1994. Endocrine hypertension: thyroid disease and acromegaly. In: Swales J.D. (ed.) Textbook of Hypertension, pp. 959-968. Blackwell Science Publishing, Oxford.
9. Cryer, P.E. 1975. Plasma norepinephrine and epinephrine in acromegaly. J Clin Endocrinol Metab 41, 542-545.
10. Eisenhofer, G., Friberg, P., Rundqvist, B. et al. 1996. Cardiac sympathetic nerve function in congestive heart failure. Circulation 93, 1667-1676.
11. Esler, M., Kaye, D., Lambert, G., Esler, D. & Jennings, G. 1997. Adrenergic nervous system in heart failure. Am J Cardiol 80, 7L-14L.
12. Fitzgerald, S.M., Gan, L., Wickman, A. & Bergstrom, G. 2003. Cardiovascular and renal phenotyping of genetically modified mice: a challenge for traditional physiology. Clin Exp Pharmacol Physiol 30, 207-216.
13. Fu, M.L., Tornell, J., Schulze, W. et al. 2000. Myocardial hypertrophy in transgenic mice overexpressing the bovine growth hormone (bGH) gene. J Intern Med 247, 546-552.
14. Gehrmann, J., Hammer, P.E., Maguire, C.T., Wakimoto, H., Triedman, J.K. & Berul, C.I. 2000. Phenotypic screening for heart rate variability in the mouse. Am J Physiol Heart Circ Physiol 279, H733-H740.
15. Hoffman, B.B. & Taylor, P. 2001. Neurotransmission. In: J.G. Hardman, L.E. Limbird & A.G. Gilman (eds) The Pharmacological Basis of Theraputics, pp. 115-154. McGraw Hill, New York.
16. Janssen, B.J. & Smits, J.F. 2002. Autonomic control of blood pressure in mice: Basic physiology and effects of genetic modification. Am J Physiol Regul Integr Comp Physiol 282, 1545-1564.
17. Johansson, C. & Thoren, P. 1997. The effects of triiodothyronine (t3) on heart rate, temperature and ECG measured with telemetry in freely moving mice. Acta Physiol Scand 160, 133-138.
18. Jumrussirikul, P., Dinerman, J., Dawson, T.M. et al. 1998. Interaction between neuronal nitric oxide synthase and inhibitory g protein activity in heart rate regulation in conscious mice. J Clin Invest 102, 1279-1285.
19. Just, A., Faulhaber, J. & Ehmke, H. 2000. Autonomic cardiovascular control in conscious mice. Am J Physiol Regul Integr Comp Physiol 279, R2214-R2221.
20. Kujacic, M., Svensson, K., Lofberg, L. & Carlsson, A. 1990. Acute changes in dopamine levels in rat adrenal glands after administration of dopamine receptor agonists and antagonists. Eur J Pharmacol 177, 163-170.
21. La Rovere, M.T., Bigger, J.T. Jr., Marcus, F.I., Mortara, A. & Schwartz, P.J. 1998. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Atrami (autonomic tone and reflexes after myocardial infarction) investigators. Lancet 351, 478-484.
22. Lykkegard, S. & Poulsen, K. 1976. Ultramicroassay for plasma renin concen-tration in the rat using the antibody-trapping technique. Anal Biochem 75, 250-259.
23. Malik, M. 1996. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task force of the european society of cardiology and the north american society of pacing and electrophysiology. Circulation 93, 1043-1065.
24. Meredith, I.T., Broughton, A., Jennings, G.L. & Esler, M.D. 1991. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med 325, 618-624.
25. Omerovic, E., Bollano, E., Mobini, R. et al. 2000. Growth hormone improves bioenergetics and decreases catechol-amines in postinfarct rat hearts. Endocrinology 141, 4592-4599.
26. Rozenberg, I., Manchon, P., Sabatier, C., Hazard, J. & Lhoste, F. 1985. Effects of thyrotrophin-releasing hormone on plasma catecholamine levels in acro-megalics. Acta Endocrinol (Copenh) 109, 19-24.
27. Sandstedt, J., Ohlsson, C., Norjavaara, E., Nilsson, J. & Tornell, J. 1994. Disproportional bone growth and reduced weight gain in gonadectomized male bovine growth hormone transgenic and normal mice. Endocrinology 135, 2574-2580.
28. Scott, E.M., Greenwood, J.P., Stoker, J.B., Mary, D.A.S.G. & Gilbey, S.G. 2002. Sympathetic nerve hyperactivity is associated with increased peripheral vascular resistance in hypopituitary patients with growth hormone deficiency. Clin Endocrinol 56, 759-763.
29. Sverrisdottir, Y.B., Elam, M., Herlitz, H., Bengtsson, B.A. & Johannsson, G. 1998. Intense sympathetic nerve activity in adults with hypopituitarism and untreated growth hormone deficiency. J Clin Endocrinol Metab 83, 1881-1885.
30. Sverrisdottir, Y.B., Elam, M., Caidahl, K., Soderling, A.S., Herlitz, H. & Johannsson, G. 2003. The effect of growth hormone (gh) replacement therapy on sympathetic nerve hyper-activity in hypopituitary adults: a double-blind, placebo-controlled, cross-over, short-term trial followed by long-term open gh replacement in hypo-pituitary adults. J Hypertens 21, 1905-1914.
31. Uechi, M., Asai, K., Osaka, M. et al. 1998. Depressed heart rate variability and arterial baroreflex in conscious transgenic mice with overexpression of cardiac gsalpha. Circ Res 82, 416-423.
32. Van Loon, G.R. 1979. Abnormal plasma catecholamine responses in acromegalics. J Clin Endocrinol Metab 48, 784-789.